SEC Filing Summary: Form 8-K
Business Context and Reporting Period
This Form 8-K was filed by AspenBio Pharma, Inc. on August 10, 2009. The registrant is incorporated in Colorado with principal executive offices in Castle Rock, CO. The filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Note: The request metadata references "Riot Platforms, Inc.", but the provided filing text explicitly identifies the registrant as "AspenBio Pharma, Inc." This summary reflects the content of the provided text.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of non-financial corporate information rather than a financial results statement.
Material Changes
The filing discloses the following material updates under Item 7.01 (Regulation FD Disclosure):
- Incorporation by reference of a PowerPoint presentation (Exhibit 99.1) dated August 2009.
- Incorporation by reference of updated Corporate Profile information (Exhibit 99.2) dated August 2009.
Both exhibits are noted as being available on the Company's website.
Guidance, Outlook, and Risks
The filing text does not contain specific management commentary, financial guidance, risk factors, or contingencies. The content is limited to the procedural disclosure of the attached exhibits.
Key Facts for Investor Verification
- Verify the contents of the "Power Point Presentation" (Exhibit 99.1) and "Corporate Profile" (Exhibit 99.2) on the company's website, as the filing incorporates them by reference.
- Confirm the identity of the registrant as AspenBio Pharma, Inc., distinct from Riot Platforms, Inc.
- Note that no quantitative financial data is included in this specific 8-K filing.